Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Stroke

Free Subscription Articles published in Lancet Retrieve available abstracts of 135 articles: HTML format

Single Articles

March 2026
1. LANE DA, Andrade JG, Arbelo E, Boriani G, et al
   Atrial fibrillation.
   Lancet. 2026;407:1000-1013.
   PubMed     Abstract available
   
   
   February 2026
2. 
   Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.
   Lancet. 2026;407:689-703.
   PubMed     Abstract available
   
   
   
3. XIONG Y, Alemseged F, Cao Z, Schwamm LH, et al
   Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
   Lancet. 2026 Feb 5:S0140-6736(25)02633-9. doi: 10.1016/S0140-6736(25)02633.
   PubMed     Abstract available
   
   
   
4. TSIVGOULIS G, Palaiodimou L, Turc G
   Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion.
   Lancet. 2026 Feb 5:S0140-6736(26)00139-X. doi: 10.1016/S0140-6736(26)00139.
   PubMed    
   
   
   
5. ANDERSON CS, Chen C, Salman RA
   Testing early haemostatic therapy for acute intracerebral haemorrhage.
   Lancet. 2026 Feb 4:S0140-6736(26)00146-7. doi: 10.1016/S0140-6736(26)00146.
   PubMed    
   
   
   
6. BRODERICK JP, Naidech AM, Elm JJ, Toyoda K, et al
   Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
   Lancet. 2026 Feb 4:S0140-6736(26)00097-8. doi: 10.1016/S0140-6736(26)00097.
   PubMed     Abstract available
   
   
   January 2026
7. WENZL FA, Ow KW, Velders MA, Tyrer F, et al
   Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation study.
   Lancet. 2026;407:515-528.
   PubMed     Abstract available
   
   
   
8. LU Y, Guan L, Wu J, Yang Q, et al
   Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial.
   Lancet. 2026 Jan 30:S0140-6736(25)01862-8. doi: 10.1016/S0140-6736(25)01862.
   PubMed     Abstract available
   
   
   
9. NAUCK MA, Tuttle KR, Tschop MH, Bluher M, et al
   Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits.
   Lancet. 2026 Jan 14:S0140-6736(25)02105-1. doi: 10.1016/S0140-6736(25)02105.
   PubMed     Abstract available
   
   
   
10. EKELUND U, Tarp J, Ding D, Sanchez-Lastra MA, et al
    Deaths potentially averted by small changes in physical activity and sedentary time: an individual participant data meta-analysis of prospective cohort studies.
    Lancet. 2026 Jan 13:S0140-6736(25)02219-6. doi: 10.1016/S0140-6736(25)02219.
    PubMed     Abstract available
    
    
    December 2025
11. 
    Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2025;404:2543-2583.
    PubMed     Abstract available
    
    
    
12. KEDHI E, Hermanides RS, Dambrink JE, Singh SK, et al
    TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and c
    Lancet. 2025;404:2593-2602.
    PubMed     Abstract available
    
    
    
13. ANDERSON CS, Sui Y, Urrutia VC
    The importance of patient selection in stroke monitoring research - Authors' reply.
    Lancet. 2025;406:2756.
    PubMed    
    
    
    
14. HAYASHI S, Yasuda T, Shiraishi A
    The importance of patient selection in stroke monitoring research.
    Lancet. 2025;406:2755-2756.
    PubMed    
    
    
    
15. MOAYAD L, Mihan A, Peters SAE, Van Spall HGC, et al
    Inclusion of women who are pregnant, lactating, or of reproductive potential in clinical trials: health, ethical, and regulatory considerations.
    Lancet. 2025;406:2858-2864.
    PubMed     Abstract available
    
    
    November 2025
16. MAKKAR RR, Thourani VH, Vahl TP, Yadav PK, et al
    Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
    Lancet. 2025 Nov 16:S0140-6736(25)02215-9. doi: 10.1016/S0140-6736(25)02215.
    PubMed     Abstract available
    
    
    
17. LEE JM
    Complete revascularisation in patients with acute myocardial infarction.
    Lancet. 2025 Nov 9:S0140-6736(25)02243-3. doi: 10.1016/S0140-6736(25)02243.
    PubMed    
    
    
    
18. KANG J, Park KW, Han JK, Hwang D, et al
    Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial.
    Lancet. 2025;406:2244-2256.
    PubMed     Abstract available
    
    
    
19. 
    Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Nov 7:S0140-6736(25)01853-7. doi: 10.1016/S0140-6736(25)01853.
    PubMed     Abstract available
    
    
    October 2025
20. FEIGIN VL, Martins SO, Hankey GJ
    Rethinking atherosclerotic disease prevention.
    Lancet. 2025;406:1947.
    PubMed    
    
    
    
21. DEANFIELD J, Lincoff AM, Kahn SE, Emerson SS, et al
    Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
    Lancet. 2025 Oct 22:S0140-6736(25)01375-3. doi: 10.1016/S0140-6736(25)01375.
    PubMed     Abstract available
    
    
    
22. 
    Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Oct 12:S0140-6736(25)01917-8. doi: 10.1016/S0140-6736(25)01917.
    PubMed     Abstract available
    
    
    
23. 
    Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Oct 12:S0140-6736(25)01330-3. doi: 10.1016/S0140-6736(25)01330.
    PubMed     Abstract available
    
    
    
24. 
    Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Stud
    Lancet. 2025 Oct 12:S0140-6736(25)01637-X. doi: 10.1016/S0140-6736(25)01637.
    PubMed     Abstract available
    
    
    September 2025
25. FRISONI GB, Aho E, Brayne C, Ciccarelli O, et al
    Alzheimer's disease outlook: controversies and future directions.
    Lancet. 2025;406:1424-1442.
    PubMed     Abstract available
    
    
    
26. FOX NC, Belder C, Ballard C, Kales HC, et al
    Treatment for Alzheimer's disease.
    Lancet. 2025;406:1408-1423.
    PubMed     Abstract available
    
    
    
27. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
    New landscape of the diagnosis of Alzheimer's disease.
    Lancet. 2025;406:1389-1407.
    PubMed     Abstract available
    
    
    
28. 
    The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Sep 24:S0140-6736(25)01635-6. doi: 10.1016/S0140-6736(25)01635.
    PubMed     Abstract available
    
    
    
29. OCHOA-URREA M, Luo X, Vilella L, Lacuey N, et al
    Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort study.
    Lancet. 2025 Sep 17:S0140-6736(25)01636-8. doi: 10.1016/S0140-6736(25)01636.
    PubMed     Abstract available
    
    
    August 2025
30. ROSSELLO X, Prescott EIB, Kristensen AMD, Latini R, et al
    beta blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials.
    Lancet. 2025 Aug 29:S0140-6736(25)01592-2. doi: 10.1016/S0140-6736(25)01592.
    PubMed     Abstract available
    
    
    
31. GUO X, Sun G, Xu Y, Zhou S, et al
    Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.
    Lancet. 2025 Aug 28:S0140-6736(25)01391-1. doi: 10.1016/S0140-6736(25)01391.
    PubMed     Abstract available
    
    
    
32. VALGIMIGLI M, Choi KH, Giacoppo D, Gragnano F, et al
    Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis.
    Lancet. 2025 Aug 28:S0140-6736(25)01562-4. doi: 10.1016/S0140-6736(25)01562.
    PubMed     Abstract available
    
    
    
33. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.
    Lancet. 2025 Aug 28:S0140-6736(25)01529-6. doi: 10.1016/S0140-6736(25)01529.
    PubMed     Abstract available
    
    
    
34. ANDERSON CS, Hua C, Wang Z, Wang C, et al
    Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China.
    Lancet. 2025 Aug 28:S0140-6736(25)01485-0. doi: 10.1016/S0140-6736(25)01485.
    PubMed     Abstract available
    
    
    
35. ROSSIGNOL P, Zannad F, Massy Z, Azizi M, et al
    Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.
    Lancet. 2025;406:705-718.
    PubMed     Abstract available
    
    
    
36. ROSENTHAL LS, Farag M, Aziz NA, Bang J, et al
    Vesicular monoamine transport inhibitors: current uses and future directions.
    Lancet. 2025;406:650-664.
    PubMed     Abstract available
    
    
    
37. CHENG SP, Chen PH, Jhou HJ
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:601.
    PubMed    
    
    
    
38. WERRING DJ, Dehbi HM, Best JG, Nash PS, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke - Authors' reply.
    Lancet. 2025;406:601-602.
    PubMed    
    
    
    
39. POCAR M, Barbero C, Cerrato P, De Rosa FG, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:600-601.
    PubMed    
    
    
    June 2025
40. 
    Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed     Abstract available
    
    
    
41. ZIAI WC, Tsivgoulis G
    Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
    Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
    PubMed    
    
    
    
42. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
    Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
    Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
    PubMed     Abstract available
    
    
    
43. DENT E, Clegg A, Roller-Wirnsberger R, Vetrano DL, et al
    Reorienting frailty in clinical practice, public health, and policy: the Lancet Commission on Frailty.
    Lancet. 2025 Jun 5:S0140-6736(25)01101-8. doi: 10.1016/S0140-6736(25)01101.
    PubMed    
    
    
    May 2025
44. ASHCRAFT S
    Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.
    Lancet. 2025;405:1884-1885.
    PubMed    
    
    
    
45. SHNEIDER NA, Harms MB, Korobeynikov VA, Rifai OM, et al
    Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
    Lancet. 2025 May 22:S0140-6736(25)00513-6. doi: 10.1016/S0140-6736(25)00513.
    PubMed     Abstract available
    
    
    
46. ANDERSON CS, Summers D, Ouyang M, Sui Y, et al
    Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferio
    Lancet. 2025 May 20:S0140-6736(25)00549-5. doi: 10.1016/S0140-6736(25)00549.
    PubMed     Abstract available
    
    
    
47. MAKKAR RR, Ramana RK, Gnall E, Ramlawi B, et al
    ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial.
    Lancet. 2025 May 20:S0140-6736(25)00319-8. doi: 10.1016/S0140-6736(25)00319.
    PubMed     Abstract available
    
    
    
48. SONG L, Li Q, Anderson CS
    Traditional Chinese medicine for acute intracerebral haemorrhage - Authors' reply.
    Lancet. 2025;405:1741-1742.
    PubMed    
    
    
    March 2025
49. CHOI KH, Park YH, Lee JY, Jeong JO, et al
    Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449.
    PubMed     Abstract available
    
    
    
50. FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al
    Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505.
    PubMed     Abstract available
    
    
    
51. 
    Global, regional, and national burden of household air pollution, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2025 Mar 18:S0140-6736(24)02840-X. doi: 10.1016/S0140-6736(24)02840.
    PubMed     Abstract available
    
    
    February 2025
52. 
    Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
    Lancet. 2025 Feb 28:S0140-6736(25)00355-1. doi: 10.1016/S0140-6736(25)00355.
    PubMed     Abstract available
    
    
    
53. 
    Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
    Lancet. 2025 Feb 28:S0140-6736(25)00397-6. doi: 10.1016/S0140-6736(25)00397.
    PubMed     Abstract available
    
    
    
54. SALMAN RA, Shoamanesh A
    Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage.
    Lancet. 2025 Feb 26:S0140-6736(25)00366-6. doi: 10.1016/S0140-6736(25)00366.
    PubMed    
    
    
    
55. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available
    
    
    
56. CHRISTENSON J, Hill MD, Swartz RH, Adams C, et al
    Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
    Lancet. 2025;405:571-582.
    PubMed     Abstract available
    
    
    
57. HILL MD, Goyal M, Demchuk AM, Menon BK, et al
    Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2025;405:560-570.
    PubMed     Abstract available
    
    
    
58. KOOHI N, Simonyan S, Joffily L, Simister R, et al
    Testing hearing in suspected stroke: a diagnostic opportunity.
    Lancet. 2025;405:540-541.
    PubMed    
    
    
    
59. LIBERMAN AL, Levine SR
    Ischaemic brain neuroprotection: a true therapeutic frontier?
    Lancet. 2025;405:519-521.
    PubMed    
    
    
    
60. LI W, Lan J, Wei M, Liu L, et al
    Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.
    Lancet. 2025;405:486-497.
    PubMed     Abstract available
    
    
    
61. DIPPEL DWJ, Janssen PM
    Effect of normobaric hyperoxia in ischaemic stroke.
    Lancet. 2025;405:442-443.
    PubMed    
    
    
    January 2025
62. WILLIAMS MC, Wereski R, Tuck C, Adamson PD, et al
    Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
    Lancet. 2025;405:329-337.
    PubMed     Abstract available
    
    
    December 2024
63. NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al
    Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.
    Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820.
    PubMed     Abstract available
    
    
    
64. HO JK, Hankey GJ
    Endovascular therapy for ischaemic stroke due to vertebrobasilar artery occlusion.
    Lancet. 2024 Dec 11:S0140-6736(24)02137-8. doi: 10.1016/S0140-6736(24)02137.
    PubMed    
    
    
    
65. 
    Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2341-2370.
    PubMed     Abstract available
    
    
    
66. 
    The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2314-2340.
    PubMed     Abstract available
    
    
    November 2024
67. DHILLON PS, Nguyen TN
    Temporary blood flow arrest during endovascular thrombectomy for acute ischaemic stroke.
    Lancet. 2024 Nov 20:S0140-6736(24)02461-9. doi: 10.1016/S0140-6736(24)02461.
    PubMed    
    
    
    
68. LIU J, Zhou Y, Zhang L, Li Z, et al
    Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315.
    PubMed     Abstract available
    
    
    
69. 
    National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.
    Lancet. 2024 Nov 12:S0140-6736(24)01548-4. doi: 10.1016/S0140-6736(24)01548.
    PubMed     Abstract available
    
    
    
70. WU S
    Integrative medicine for the treatment of stroke.
    Lancet. 2024 Nov 12:S0140-6736(24)02257-8. doi: 10.1016/S0140-6736(24)02257.
    PubMed    
    
    
    
71. GUO J, Chen X, Wu M, Wang D, et al
    Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial.
    Lancet. 2024 Nov 12:S0140-6736(24)02261-X. doi: 10.1016/S0140-6736(24)02261.
    PubMed     Abstract available
    
    
    
72. 
    Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925.
    PubMed     Abstract available
    
    
    
73. THOMALLA G, Bonekamp S, Fiehler J, Bendszus M, et al
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial - Authors' reply.
    Lancet. 2024;404:1729-1730.
    PubMed    
    
    
    
74. JHOU HJ, Yang LY, Chen PH
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728.
    PubMed    
    
    
    
75. WANG Z, Huang K, Huang ZX
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728-1729.
    PubMed    
    
    
    
76. BROOCKS G, Kemmling A
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1727-1728.
    PubMed    
    
    
    October 2024
77. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available
    
    
    
78. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    
    
    
    September 2024
79. NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al
    Endovascular management of acute stroke.
    Lancet. 2024;404:1265-1278.
    PubMed     Abstract available
    
    
    
80. NARAGHI K, Marzo-Ortega H
    Progressive cervical osteophytosis and dysphagia associated with isotretinoin treatment for rosacea.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
81. 
    Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01867-1. doi: 10.1016/S0140-6736(24)01867.
    PubMed     Abstract available
    
    
    August 2024
82. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
    Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
    PubMed     Abstract available
    
    
    
83. VALGIMIGLI M, Hong SJ, Gragnano F, Chalkou K, et al
    De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
    Lancet. 2024 Aug 30:S0140-6736(24)01616-7. doi: 10.1016/S0140-6736(24)01616.
    PubMed     Abstract available
    
    
    
84. JHUND PS, Talebi A, Henderson AD, Claggett BL, et al
    Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.
    Lancet. 2024 Aug 30:S0140-6736(24)01733-1. doi: 10.1016/S0140-6736(24)01733.
    PubMed     Abstract available
    
    
    
85. KOSIBOROD MN, Deanfield J, Pratley R, Borlaug BA, et al
    Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
    Lancet. 2024 Aug 29:S0140-6736(24)01643-X. doi: 10.1016/S0140-6736(24)01643.
    PubMed     Abstract available
    
    
    
86. DEANFIELD J, Verma S, Scirica BM, Kahn SE, et al
    Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
    Lancet. 2024;404:773-786.
    PubMed     Abstract available
    
    
    
87. JAVED S, Zaidi DA, Yaqoob E
    Addressing the deficiencies in stroke care in Pakistan.
    Lancet. 2024;404:651-652.
    PubMed    
    
    
    
88. COUTTS SB, Sprigg N
    Human rights considerations are key when choosing a conference location.
    Lancet. 2024 Aug 16:S0140-6736(24)01503-4. doi: 10.1016/S0140-6736(24)01503.
    PubMed    
    
    
    
89. MANLEY GT, Maas AI
    The Glasgow Coma Scale at 50: looking back and forward.
    Lancet. 2024 Aug 14:S0140-6736(24)01596-4. doi: 10.1016/S0140-6736(24)01596.
    PubMed    
    
    
    July 2024
90. JOUNDI RA, Hu B, Rangarajan S, Leong DP, et al
    Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study.
    Lancet. 2024 Jul 25:S0140-6736(24)01050-X. doi: 10.1016/S0140-6736(24)01050.
    PubMed     Abstract available
    
    
    June 2024
91. LIU J, Li Y, Ge J, Yan X, et al
    Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
    PubMed     Abstract available
    
    
    
92. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available
    
    
    
93. KATSANOS AH, Shoamanesh A
    Colchicine for the prevention of vascular events after non-cardioembolic stroke.
    Lancet. 2024 Jun 7:S0140-6736(24)01096-1. doi: 10.1016/S0140-6736(24)01096.
    PubMed    
    
    
    May 2024
94. BAUMBACH A, van Royen N, Amat-Santos IJ, Hudec M, et al
    LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
    Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821.
    PubMed     Abstract available
    
    
    
95. 
    Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2204-2256.
    PubMed     Abstract available
    
    
    
96. 
    Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2162-2203.
    PubMed     Abstract available
    
    
    
97. ADLER AI, Coleman RL, Leal J, Whiteley WN, et al
    Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
    Lancet. 2024 May 17:S0140-6736(24)00537-3. doi: 10.1016/S0140-6736(24)00537.
    PubMed     Abstract available
    
    
    
98. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    PubMed     Abstract available
    
    
    
99. SACCO S, Turc G
    Advances and challenges in the acute treatment of minor ischaemic stroke.
    Lancet. 2024 May 16:S0140-6736(24)00981-4. doi: 10.1016/S0140-6736(24)00981.
    PubMed    
    
    
    
100. HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al
     Stroke.
     Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642.
     PubMed     Abstract available
     
     
     
101. BECK J, Fung C, Strbian D, Butikofer L, et al
     Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.
     Lancet. 2024 May 14:S0140-6736(24)00702-5. doi: 10.1016/S0140-6736(24)00702.
     PubMed     Abstract available
     
     
     
102. KLIJN CJ, Dammers R, Sprigg N
     Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes?
     Lancet. 2024 May 14:S0140-6736(24)00703-7. doi: 10.1016/S0140-6736(24)00703.
     PubMed    
     
     
     April 2024
103. 
     Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
     Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
     PubMed     Abstract available
     
     
     
104. GE Z, Kan J, Gao X, Raza A, et al
     Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
     Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
     PubMed     Abstract available
     
     
     
105. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
     Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
     Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
     PubMed     Abstract available
     
     
     
106. 
     Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
     Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
     PubMed     Abstract available
     
     
     March 2024
107. VAHL TP, Thourani VH, Makkar RR, Hamid N, et al
     Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
     Lancet. 2024 Mar 26:S0140-6736(23)02806-4. doi: 10.1016/S0140-6736(23)02806.
     PubMed     Abstract available
     
     
     
108. MELLO A, Stehr D, Bujarski K, Duchaine B, et al
     Visualising facial distortions in prosopometamorphopsia.
     Lancet. 2024;403:1176.
     PubMed    
     
     
     
109. 
     Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
     Lancet. 2024 Mar 19:S0140-6736(24)00550-6. doi: 10.1016/S0140-6736(24)00550.
     PubMed     Abstract available
     
     
     
110. CHEN WG, Edwards E, Iyengar S, Finkelstein R, et al
     Music and medicine: quickening the tempo of progress.
     Lancet. 2024 Mar 18:S0140-6736(24)00477-X. doi: 10.1016/S0140-6736(24)00477.
     PubMed    
     
     
     
111. 
     Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
     Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
     PubMed     Abstract available
     
     
     February 2024
112. CONSOLI A, Gory B
     Long-term results of mechanical thrombectomy for large ischaemic stroke.
     Lancet. 2024 Feb 8:S0140-6736(24)00158-2. doi: 10.1016/S0140-6736(24)00158.
     PubMed    
     
     
     
113. SARRAJ A, Abraham MG, Hassan AE, Blackburn S, et al
     Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.
     Lancet. 2024 Feb 8:S0140-6736(24)00050-3. doi: 10.1016/S0140-6736(24)00050.
     PubMed     Abstract available
     
     
     January 2024
114. BEN-SHLOMO Y, Darweesh S, Llibre-Guerra J, Marras C, et al
     The epidemiology of Parkinson's disease.
     Lancet. 2024;403:283-292.
     PubMed     Abstract available
     
     
     November 2023
115. FROST R, Avgerinou C, Kalwarowsky S, Mahmood F, et al
     Enabling health and maintaining independence for older people at home (HomeHealth trial): a multicentre randomised controlled trial.
     Lancet. 2023;402 Suppl 1:S42.
     PubMed     Abstract available
     
     
     
116. BARRADO-MARTIN Y, Frost R, Catchpole J, Rookes T, et al
     Goal setting as part of a holistic intervention to promote independence in older people with mild frailty: a process evaluation alongside a randomised controlled trial.
     Lancet. 2023;402 Suppl 1:S1.
     PubMed     Abstract available
     
     
     
117. LIU L, Li X, Marshall IJ, Bhalla A, et al
     Trajectories of depressive symptoms 10 years after stroke and associated risk factors: a prospective cohort study.
     Lancet. 2023;402 Suppl 1:S64.
     PubMed     Abstract available
     
     
     October 2023
118. MESSERLI FH, Bangalore S, Mandrola JM
     beta blockers switched to first-line therapy in hypertension.
     Lancet. 2023 Oct 13:S0140-6736(23)01733-6. doi: 10.1016/S0140-6736(23)01733.
     PubMed     Abstract available
     
     
     
119. DIPPEL DWJ, Roozenbeek B
     Thrombectomy for acute ischaemic stroke without advanced imaging.
     Lancet. 2023 Oct 10:S0140-6736(23)02229-8. doi: 10.1016/S0140-6736(23)02229.
     PubMed    
     
     
     
120. BENDSZUS M, Fiehler J, Subtil F, Bonekamp S, et al
     Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
     Lancet. 2023 Oct 10:S0140-6736(23)02032-9. doi: 10.1016/S0140-6736(23)02032.
     PubMed     Abstract available
     
     
     August 2023
121. MAKKAR RR, Kapadia S, Chakravarty T, Cubeddu RJ, et al
     Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.
     Lancet. 2023 Aug 31:S0140-6736(23)01636-7. doi: 10.1016/S0140-6736(23)01636.
     PubMed     Abstract available
     
     
     
122. MAJOIE CB, Cavalcante F, Gralla J, Yang P, et al
     Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials.
     Lancet. 2023 Aug 25:S0140-6736(23)01142-X. doi: 10.1016/S0140-6736(23)01142.
     PubMed     Abstract available
     
     
     
123. HANKEY GJ
     Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
     Lancet. 2023 Aug 25:S0140-6736(23)01202-3. doi: 10.1016/S0140-6736(23)01202.
     PubMed    
     
     
     
124. WILKOFF BL, Filippatos G, Leclercq C, Gold MR, et al
     Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
     Lancet. 2023 Aug 24:S0140-6736(23)00912-1. doi: 10.1016/S0140-6736(23)00912.
     PubMed     Abstract available
     
     
     July 2023
125. STRANDELL A, Hellgren M
     Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia.
     Lancet. 2023;402:6-7.
     PubMed    
     
     
     June 2023
126. HUANG C, Huang L, Wang Y, Li X, et al
     6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
     Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
     PubMed     Abstract available
     
     
     May 2023
127. MA L, Hu X, Song L, Chen X, et al
     The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
     Lancet. 2023 May 24:S0140-6736(23)00806-1. doi: 10.1016/S0140-6736(23)00806.
     PubMed     Abstract available
     
     
     April 2023
128. WARDLAW JM
     Even more benefit with endovascular treatment for patients with acute ischaemic stroke: MR CLEAN-LATE.
     Lancet. 2023;401:1317-1319.
     PubMed    
     
     
     
129. HAWKEY C
     Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.
     Lancet. 2023;401:1266.
     PubMed    
     
     
     
130. GATTA L, Zullo A, Vaira D
     Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.
     Lancet. 2023;401:1265-1266.
     PubMed    
     
     
     
131. LI Y, Liang Z, Stone GW, Han Y, et al
     BRIGHT-4 trial: bivalirudin strikes back - Authors' reply.
     Lancet. 2023;401:1158.
     PubMed    
     
     
     
132. PIRIOU PG, Manigold T, Letocart V, Guerin P, et al
     BRIGHT-4 trial: bivalirudin strikes back.
     Lancet. 2023;401:1157-1158.
     PubMed    
     
     
     March 2023
133. OLTHUIS SGH, Pirson FAV, Pinckaers FME, Hinsenveld WH, et al
     Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase
     Lancet. 2023 Mar 29:S0140-6736(23)00575-5. doi: 10.1016/S0140-6736(23)00575.
     PubMed     Abstract available
     
     
     
134. KLOK FA, Siegerink B
     Ordinal outcomes add value to clinical trials.
     Lancet. 2023;401:995.
     PubMed    
     
     
     
135. HE J, Ouyang N, Guo X, Sun G, et al
     Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
     Lancet. 2023 Mar 2:S0140-6736(22)02603-4. doi: 10.1016/S0140-6736(22)02603.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum